J. Goldman & Co’s ICU Medical ICUI Stock Holding History

J. Goldman & Co’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-11,043	Closed	-$2.23M	–	294
2020 Q1	$2.23M	Buy	+11,043	New	+$2.13M	0.27%	91

Other funds holding ICUI

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FPP

Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return

Nitorum Capital New York $114M AUM 17.21% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

J. Goldman & Co's ICUI Position: Q2 2020 in Review

J. Goldman & Co sold out of ICU Medical (ICUI) in Q2 2020, closing a stake of 11,043 shares — an estimated $2.23M sold.

J. Goldman & Co first reported a position in ICUI in Q1 2020 and held it in 1 quarter. The position peaked at $2.23M in Q1 2020. 294 funds tracked by Wall St. Rank hold ICUI as of Q2 2020.

J. Goldman & Co reported no remaining ICU Medical position as of Q2 2020 after selling out during the quarter.
J. Goldman & Co sold 11,043 ICU Medical shares in Q2 2020, an estimated $2.23M.
J. Goldman & Co first reported a position in ICU Medical in Q1 2020 and held it in 1 quarter.
J. Goldman & Co's ICU Medical position peaked at $2.23M in Q1 2020.
294 funds tracked by Wall St. Rank held ICU Medical as of Q2 2020.

Based on J. Goldman & Co's 13F filing for Q2 2020, filed 14 Aug 2020.